Sleep-Safe: A Strong African American Families Study

October 26, 2022 updated by: Justin Lavner, University of Georgia
Rapid weight gain during infancy is a powerful, and potentially malleable, risk factor for later overweight and obesity, but limited research has examined the impact of promising interventions when applied to the groups most at risk for rapid weight gain in infancy. The present study examines whether providing mothers of newborns with responsive parenting guidance during the first weeks of life to promote infant sleep and soothing can reduce rapid weight gain for African American infants born in low SES contexts.

Study Overview

Status

Completed

Conditions

Detailed Description

The study design is a randomized controlled trial. This trial will deliver a responsive parenting intervention (Sleep Soothe) to provide information on how to soothe, how to distinguish hunger from other distress, how to promote self-soothing, and bedtime routines. The responsive parenting intervention will be compared to a safety control group (Sleep Safe). The programs will be delivered across 2 sessions at 3-weeks and 8-weeks postpartum. Both interventions and all data collection will be delivered in participants' homes. Assessments will be conducted in participants' homes at 1-week postpartum, 3 weeks postpartum, 8 weeks postpartum, and 16-weeks postpartum.

Three hundred African American infants and their mothers will be recruited from the mother/baby nursery at Augusta University Medical Center. A dedicated recruitment coordinator will have access to electronic medical records systems in order to pre-screen mothers and infants. The recruitment coordinator will approach those who match basic inclusion criteria and will deliver an approved verbal script to pre-screened mothers to determine interest in participation. Interested mothers will respond to remaining screening questions in order to confirm eligibility. Once enrollment criteria are satisfied, informed consent will be obtained from the infant's mother during her hospital stay. Mothers will also complete selected demographic information. Anthropometric measurements will be obtained on the infant, mother, and father (optional). After enrollment, families will be scheduled for a research visit at their home at 1 week postpartum.

At home visit 1 (7-10 days postpartum), mothers (and fathers, if interested) will complete questionnaire measures using Qualtrics. There will also be measurements of infant weight and length. Families will be randomized to condition following this visit.

At home visit 2 (3 weeks postpartum), families will receive either the responsive parenting intervention or the safety control intervention. They will complete brief questionnaires. Measures of infant, maternal, and paternal (optional) weight will be obtained.

At home visit 3 (8 weeks postpartum), families will receive either the second part of the responsive parenting intervention or the second part of the safety control intervention. They will complete brief questionnaires. Measures of infant, maternal, and (optional: paternal) weight will be obtained. Mothers will be provided with activity monitors for themselves and for their babies that will be picked up by study staff after 7 days' use.

At home visit 4 (16 weeks postpartum), mothers will complete questionnaire measures (fathers' participation is optional). Measures of maternal and paternal (optional) weight will be obtained, as will measures of infant weight, length, and head circumference.

We test the following specific aims:

Specific Aim 1: To assess the effects of responsive parenting, focused on infant sleep and soothing, on reducing rapid weight gain from 3 to 16 weeks among African American infants. We hypothesize that infants in the Sleep Soothe condition will gain weight more slowly compared to infants in the Sleep Safe condition and have lower weight outcomes (i.e., BMI z scores, weight-for-length z scores, weight-for-age z scores) at age 16 weeks.

Specific Aim 2: To assess effects of responsive parenting on parental and infant behaviors. We hypothesize that compared with parents in the Sleep Safe condition, parents in the Sleep Soothe condition will show increases in responsive parenting, parenting self-efficacy, and the use of alternatives to feeding to soothe (white noise, pacifier, etc.), and decreases in feeding to soothe. Over time, infants in this condition will have longer sleep bouts and fewer feedings.

Specific Aim 3: To examine moderation of intervention effects by individual and contextual factors.

Study Type

Interventional

Enrollment (Actual)

234

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Athens, Georgia, United States, 30602
        • University of Georgia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Infant > 37 0/7 weeks gestational age, apparently healthy and without significant morbidity
  2. Singleton infant
  3. Nursery/NICU/maternity stay of 7 days or less
  4. Mother at least 17 years of age
  5. Mother self-identifies as African American
  6. Mother is primiparous

Exclusion Criteria:

  1. Non-English speaking
  2. Infant birth weight <2500 grams
  3. Presence of a congenital anomaly or neonatal physical or metabolic condition that significantly affects a newborn's feeding (e.g. cleft lip, cleft palate, metabolic disease)
  4. Any major maternal morbidities, pre-existing condition that would affect postpartum care or her ability to care for her newborn (e.g., narcotic drug use: heroin, cocaine, meth, pain pills, etc; on chemotherapy; uncontrolled MS; uncontrolled depression causing social service contact).
  5. Plan for newborn to be adopted
  6. Plan to move from area within four months of delivery
  7. Residence further than 75 miles from Augusta, GA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sleep Soothe
An intervention in which parents are given information on how to respond to their baby's cues related to sleeping and fussiness.
An intervention in which parents are given information on how to respond to their baby's cues related to sleeping and fussiness.
Active Comparator: Sleep Safe
An intervention in which parents are given information on a safe sleep environment, as well as other strategies to keep baby safe
An intervention in which parents are given information on a safe sleep environment, as well as other strategies to keep baby safe.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in infants' weight for age from 3 weeks to 16 weeks (conditional weight gain)
Time Frame: 3 weeks to 16 weeks
Standardized residuals from the linear regression of weight for age at 16 weeks on weight for age at 3 weeks, with length for age at birth and 16 weeks and infant age at the 16-week assessment entered as covariates
3 weeks to 16 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in infants' weight for age
Time Frame: 3 weeks to 16 weeks
Growth curve models of change in infants' weight for age
3 weeks to 16 weeks
Weight-for-age z scores
Time Frame: 16 weeks
Weight-for-age z scores at 16 weeks
16 weeks
Weight-for-length z scores
Time Frame: 16 weeks
Weight-for-length z scores at 16 weeks
16 weeks
Infant BMI z scores
Time Frame: 16 weeks
BMI z scores at 16 weeks
16 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal report of infant sleep at 8 weeks
Time Frame: 8 weeks
Sleep duration and number of night awakenings using the Brief Infant Sleep Questionnaire (Sadeh, 2004)
8 weeks
Maternal report of infant sleep at 16 weeks
Time Frame: 16 weeks
Sleep duration and number of night awakenings using the Brief Infant Sleep Questionnaire (Sadeh, 2004)
16 weeks
Maternal sleep actigraphy
Time Frame: 8 weeks postpartum
7-day actigraphy data to assess mothers' sleep duration
8 weeks postpartum
Infant soothing at 8 weeks
Time Frame: 8 weeks
Parents use feeding for reasons other than in response to hunger
8 weeks
Infant soothing at 16 weeks
Time Frame: 16 weeks
Parents use feeding for reasons other than in response to hunger
16 weeks
Infant feeding frequency at 16 weeks
Time Frame: 16 weeks
Feeding frequency, use of bottle feeding, and introduction of solids using Babies Need Feeding (Stifter et al., 2011)
16 weeks
Safe sleep practices
Time Frame: 16 weeks
Frequency of sleep safety practices (Fowler et al., 2013)
16 weeks
Child safety practices
Time Frame: 16 weeks
Child safety practices assessed using the Framingham Safety Survey (Hansen et al., 1996)
16 weeks
Infant eating behavior
Time Frame: 16 weeks
Infant eating behavior using the Baby Eating Behavior Questionnaire (Llewellyn et al., 2011)
16 weeks
Parental self-efficacy at 8 weeks
Time Frame: 8 weeks
Perceived parental self-efficacy at 8 weeks using total score from the Karitane Parenting Confidence Scale (Crncec, Barnett, & Matthey, 2008)
8 weeks
Parental self-efficacy at 16 weeks
Time Frame: 16 weeks
Perceived parental self-efficacy at 16 weeks using total score from the Karitane Parenting Confidence Scale (Crncec, Barnett, & Matthey, 2008)
16 weeks
Maternal feeding practices and beliefs at 8 weeks
Time Frame: 8 weeks
Maternal feeding beliefs and behaviors using the Infant Feeding Styles Questionnaire (Thompson et al., 2009)
8 weeks
Maternal feeding practices and beliefs at 16 weeks
Time Frame: 16 weeks
Maternal feeding beliefs and behaviors using the Infant Feeding Styles Questionnaire (Thompson et al., 2009)
16 weeks
Maternal depressive symptoms at 8 weeks
Time Frame: 8 weeks
Maternal depressive symptoms at 8 weeks using the CES-D (Radloff, 1977)
8 weeks
Maternal depressive symptoms at 16 weeks
Time Frame: 16 weeks
Maternal depressive symptoms at 16 weeks using the CES-D (Radloff, 1977)
16 weeks
Family routines
Time Frame: 8 weeks
Extent to which there is order and routine versus chaos and confusion in their home. Uses total score from the Confusion, Hubbub, and Order Scale (Matheny et al., 1995)
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Justin A Lavner, Ph.D., University of Georgia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 4, 2018

Primary Completion (Actual)

July 5, 2021

Study Completion (Actual)

July 5, 2021

Study Registration Dates

First Submitted

April 3, 2018

First Submitted That Met QC Criteria

April 12, 2018

First Posted (Actual)

April 23, 2018

Study Record Updates

Last Update Posted (Actual)

October 31, 2022

Last Update Submitted That Met QC Criteria

October 26, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20180320
  • R01DK112874 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weight Gain

Clinical Trials on Sleep Soothe

3
Subscribe